Chu de Clermont Ferrand

Clermont-Ferrand 63100

0 studies enrolling now · 6 studies all time

What they study most

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Crohn's Disease, Deep Venous Thrombosis, Heart Failure, Leukemia, Lymphocytic, Chronic, B-Cell, Pulmonary Embolism, Small Lymphocytic Lymphoma

Studies at this site

• A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia — Recruiting now
• A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia — Running, not enrolling
• Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients — Running, not enrolling
• A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
• Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
• Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy — Completed